{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35990459", "DateRevised": {"Year": "2022", "Month": "08", "Day": "23"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "08", "Day": "01"}], "Language": ["eng"], "ELocationID": ["10.1021/acsomega.2c01969"], "Journal": {"ISSN": "2470-1343", "JournalIssue": {"Volume": "7", "Issue": "32", "PubDate": {"Year": "2022", "Month": "Aug", "Day": "16"}}, "Title": "ACS omega", "ISOAbbreviation": "ACS Omega"}, "ArticleTitle": "Mercaptobenzimidazole-Based 1,3-Thaizolidin-4-ones as Antidiabetic Agents: Synthesis, In Vitro \u03b1-Glucosidase Inhibition Activity, and Molecular Docking Studies.", "Pagination": {"StartPage": "28041", "EndPage": "28051", "MedlinePgn": "28041-28051"}, "Abstract": {"AbstractText": ["In this research work, we have focused our efforts to synthesize a series of 2-mercaptobenzimidazole-based 1,3-thiazolidin-4-ones (<b>5-24</b>) following a multistep reaction strategy and characterization of the synthesized derivatives with the help of various spectroscopic techniques. To find the antidiabetic potentials of the synthesized compounds (<b>5-24</b>), in vitro alpha-glucosidase inhibitory activity was performed using acarbose (IC<sub>50</sub> = 873 \u00b1 1.2 \u03bcM) as the reference standard. The results of the antidiabetic assay were very encouraging because compounds <b>5</b>, <b>8</b>, and <b>14</b> showed excellent inhibitions with IC<sub>50</sub> values of 5.22 \u00b1 0.14, 5.69 \u00b1 0.10, and 10.20 \u00b1 0.12 \u03bcM, respectively. The experimental results of anti-alpha-glucosidase activity prompted us to investigate and propose a possible mechanism of how the active molecules will interact with the target enzyme. For this purpose, molecular docking with the AutoDock Vina (an open-source and reliable docking platform) gave us an insight into the binding interactions of the active compounds to different amino acid residues of the enzyme."], "CopyrightInformation": "\u00a9 2022 The Authors. Published by American Chemical Society."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Malakand, Dir (Lower), Chakdara, Khyber Pakhtunkhwa 18800, Pakistan."}], "LastName": "Khan", "ForeName": "Sher Ali", "Initials": "SA"}, {"Identifier": ["0000-0001-7573-7953"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Malakand, Dir (Lower), Chakdara, Khyber Pakhtunkhwa 18800, Pakistan."}], "LastName": "Ali", "ForeName": "Mumtaz", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Malakand, Dir (Lower), Chakdara, Khyber Pakhtunkhwa 18800, Pakistan."}], "LastName": "Latif", "ForeName": "Abdul", "Initials": "A"}, {"Identifier": ["0000-0001-9736-5900"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Malakand, Dir (Lower), Chakdara, Khyber Pakhtunkhwa 18800, Pakistan."}], "LastName": "Ahmad", "ForeName": "Manzoor", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "UoN Chair of Oman's Medicinal Plants and Marine Natural Products, University of Nizwa, Nizwa 616, Sultanate of Oman."}], "LastName": "Khan", "ForeName": "Ajmal", "Initials": "A"}, {"Identifier": ["0000-0002-0815-5942"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "UoN Chair of Oman's Medicinal Plants and Marine Natural Products, University of Nizwa, Nizwa 616, Sultanate of Oman."}], "LastName": "Al-Harrasi", "ForeName": "Ahmed", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "ACS Omega", "NlmUniqueID": "101691658", "ISSNLinking": "2470-1343"}, "CoiStatement": "The authors declare no competing financial interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Rasool S. R.; Saadon A. Barbituric acid as a core for some new heterocyclic substituted derivatives. J. Appl. Chem. 2014, 3, 74\u201381."}, {"Citation": "Sen J.; Srivastava S. Synthesis and antimicrobial activity of some new 2-[2\u2033, 3\u2033-dinitrophenyl]-3-(substituted aryl)-3, 3a-dihydrobenzimidazo [2, 1-a] pyrazolo [3, 4-d] thiazoles derivatives. Int. J. Theor. Appl. Sci. 2009, 1, 41\u201347."}, {"Citation": "Chauhan D.; Hati S.; Priyadarshini R.; Sen S. Transcriptome analysis predicts mode of action of benzimidazole molecules against Staphylococcus aureus UAMS-1. Drug Dev. Res. 2019, 80, 490\u2013503. 10.1002/ddr.21523.", "ArticleIdList": ["10.1002/ddr.21523", "30793347"]}, {"Citation": "Ali M.; Ali S.; Khan M.; Rashid U.; Ahmad M.; Khan A.; Al-Harrasi A.; Ullah F.; Latif A. Synthesis, biological activities, and molecular docking studies of 2-mercaptobenzimidazole based derivatives. Bioorg. Chem. 2018, 80, 472\u2013479. 10.1016/j.bioorg.2018.06.032.", "ArticleIdList": ["10.1016/j.bioorg.2018.06.032", "29990895"]}, {"Citation": "Yadav S.; Narasimhan B.; Lim S. M.; Ramasamy K.; Vasudevan M.; Shah S. A. A.; Selvaraj M. Synthesis, characterization, biological evaluation and molecular docking studies of 2-(1H-benzo [d] imidazole-2-ylthio)-N-(substituted 4-oxothiazolidin-3-yl) acetamides. Chem. Cent. J. 2017, 11, 137.10.1186/s13065-017-0361-6.", "ArticleIdList": ["10.1186/s13065-017-0361-6", "PMC5741571", "29274036"]}, {"Citation": "Anandarajagopal K.; Tiwari R. N.; Bothara K.; Sunilson J. A. J.; Dineshkumar C.; Promwichit P. 2-Mercaptobenzimidazole derivatives: synthesis and anticonvulsant activity. Adv. Appl. Sci. Res. 2010, 1, 132\u2013138."}, {"Citation": "Tahlan S.; Kumar S.; Narasimhan B. Antimicrobial potential of 1 H-benzo [d] imidazole scaffold: a review. BMC Chem. 2019, 13, 18.10.1186/s13065-019-0521-y.", "ArticleIdList": ["10.1186/s13065-019-0521-y", "PMC6661827", "31384767"]}, {"Citation": "Amer H. H.; Ali O. M.; El-Kafaween I. K. Synthesis of some new nucleosides derived from 2-mercapto benzimidazole with expected biological activity. Orient. J. Chem. 2017, 33, 2303\u20132310. 10.13005/ojc/330519.", "ArticleIdList": ["10.13005/ojc/330519"]}, {"Citation": "Alkhafaji A.; Muhi-Eldeen Z.; Al-Kaissi E.; Al-Muhtaseb N.; Arafat T.; Ghattas M. A. Synthesis, structural elucidation, and evaluation of antimicrobial activity of 5-ethoxy-2-mercaptobenzimidazole derivatives. Int. J. Med. Health Res. 2018, 7, 117\u2013127."}, {"Citation": "Keri R. S.; Hiremathad A.; Budagumpi S.; Nagaraja B. M. Comprehensive review in current developments of benzimidazole-based medicinal chemistry. Chem. Biol. Drug Des. 2015, 86, 19\u201365. 10.1111/cbdd.12462.", "ArticleIdList": ["10.1111/cbdd.12462", "25352112"]}, {"Citation": "Nevade S. A.; Lokapure S. G.; Kalyane N. V. Synthesis and pharmacological evaluation of some novel 2-mercapto benzimidazole derivatives. J. Korean Chem. Soc. 2013, 57, 755\u2013760. 10.5012/jkcs.2013.57.6.755.", "ArticleIdList": ["10.5012/jkcs.2013.57.6.755"]}, {"Citation": "Syunyakov T.; Neznamov G. Evaluation of the therapeutic efficacy and safety of the selective anxiolytic afobazole in generalized anxiety disorder and adjustment disorders: Results of a multicenter randomized comparative study of diazepam. Ter. Arkh. 2016, 88, 73\u201386. 10.17116/terarkh201688873-86.", "ArticleIdList": ["10.17116/terarkh201688873-86", "27636931"]}, {"Citation": "Aboul-Enein H.; El Rashedy A. Benzimidazole derivatives as antidiabetic agents. Med. Chem. 2015, 5, 318\u2013325. 10.4172/2161-0444.1000280.", "ArticleIdList": ["10.4172/2161-0444.1000280"]}, {"Citation": "\u010ca\u010di\u0107 M.; Molnar M.; \u0160arkanj B.; Has-Sch\u00f6n E.; Rajkovi\u0107 V. Synthesis and antioxidant activity of some new coumarinyl-1, 3-thiazolidine-4-ones. Molecules 2010, 15, 6795\u20136809. 10.3390/molecules15106795.", "ArticleIdList": ["10.3390/molecules15106795", "PMC6259306", "20881932"]}, {"Citation": "Verma A.; Saraf S. K. 4-Thiazolidinone\u2013A biologically active scaffold. Eur. J. Med. Chem. 2008, 43, 897\u2013905. 10.1016/j.ejmech.2007.07.017.", "ArticleIdList": ["10.1016/j.ejmech.2007.07.017", "17870209"]}, {"Citation": "Gupta A.; Singh R.; Sonar P. K.; Saraf S. K. Novel 4-thiazolidinone derivatives as anti-infective agents: synthesis, characterization, and antimicrobial evaluation. Biochem. Res. Int. 2016, 2016, 8086762.10.1155/2016/8086762.", "ArticleIdList": ["10.1155/2016/8086762", "PMC4746384", "26925267"]}, {"Citation": "Barreca M. L.; Chimirri A.; De Luca L.; Monforte A.-M.; Monforte P.; Rao A.; Zappal\u00e0 M.; Balzarini J.; De Clercq E.; Pannecouque C.; et al. Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents. Bioorg. Med. Chem. Lett. 2001, 11, 1793\u20131796. 10.1016/s0960-894x(01)00304-3.", "ArticleIdList": ["10.1016/s0960-894x(01)00304-3", "11425562"]}, {"Citation": "Bonde C. G.; Gaikwad N. J. Synthesis and preliminary evaluation of some pyrazine containing thiazolines and thiazolidinones as antimicrobial agents. Bioorg. Med. Chem. 2004, 12, 2151\u20132161. 10.1016/j.bmc.2004.02.024.", "ArticleIdList": ["10.1016/j.bmc.2004.02.024", "15080915"]}, {"Citation": "Sigalapalli D. K.; Pooladanda V.; Kadagathur M.; Guggilapu S. D.; Uppu J. L.; Godugu C.; Bathini N. B.; Tangellamudi N. D. Novel chromenyl-based 2-iminothiazolidin-4-one derivatives as tubulin polymerization inhibitors: Design, synthesis, biological evaluation and molecular modelling studies. J. Mol. Struct. 2021, 1225, 128847.10.1016/j.molstruc.2020.128847.", "ArticleIdList": ["10.1016/j.molstruc.2020.128847"]}, {"Citation": "T\u00fcre A.; Erg\u00fcl M.; Erg\u00fcl M.; Altun A.; K\u00fc\u00e7\u00fckg\u00fczel \u0130. Design, synthesis, and anticancer activity of novel 4-thiazolidinone-phenylaminopyrimidine hybrids. Mol. Divers. 2021, 25, 1025\u20131050. 10.1007/s11030-020-10087-1.", "ArticleIdList": ["10.1007/s11030-020-10087-1", "32328961"]}, {"Citation": "Almasirad A.; Ghadimi M.; Mirahmadi S.; Ahmadian Kodakan P.; Jahani R.; Nazari M.; Rezaee E.; Azizian H.; Rabizadeh P.; Tabatabai S. A.; et al. Design, synthesis, and preliminary pharmacological evaluation of novel thiazolidinone derivatives as potential benzodiazepine agonists. Mol. Divers. 2022, 26, 769.10.1007/s11030-021-10182-x.", "ArticleIdList": ["10.1007/s11030-021-10182-x", "33484399"]}, {"Citation": "Taha M.; Shah S. A. A.; Afifi M.; Imran S.; Sultan S.; Rahim F.; Khan K. M. Synthesis, \u03b1-glucosidase inhibition and molecular docking study of coumarin based derivatives. Bioorg. Chem. 2018, 77, 586\u2013592. 10.1016/j.bioorg.2018.01.033.", "ArticleIdList": ["10.1016/j.bioorg.2018.01.033", "29477126"]}, {"Citation": "Lovell S. C.; Davis I. W.; Arendall W. B. III; de Bakker P. I.; Word J. M.; Prisant M. G.; Richardson J. S.; Richardson D. C. Structure validation by C\u03b1 geometry: \u03d5, \u03c8 and C\u03b2 deviation. Proteins: Struct., Funct., Bioinf. 2003, 50, 437\u2013450. 10.1002/prot.10286.", "ArticleIdList": ["10.1002/prot.10286", "12557186"]}, {"Citation": "Colovos C.; Yeates T. O. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. 1993, 2, 1511\u20131519. 10.1002/pro.5560020916.", "ArticleIdList": ["10.1002/pro.5560020916", "PMC2142462", "8401235"]}, {"Citation": "Benkert P.; K\u00fcnzli M.; Schwede T. QMEAN server for protein model quality estimation. Nucleic Acids Res. 2009, 37, W510\u2013W514. 10.1093/nar/gkp322.", "ArticleIdList": ["10.1093/nar/gkp322", "PMC2703985", "19429685"]}, {"Citation": "Vijayaraghavan S.; Somani R.; Shirodkar P.; Kadam V. Microwave assisted synthesis and antimicrobial activity of some newer mannich bases. Int. J. PharmTech Res. 2009, 1, 811\u2013815."}, {"Citation": "Javid M. T.; Rahim F.; Taha M.; Rehman H. U.; Nawaz M.; wadood S.; Imran I.; Uddin A.; Mosaddik K. M.; Khan K. M. Synthesis, in vitro \u03b1-glucosidase inhibitory potential and molecular docking study of thiadiazole analogs. Bioorg. Chem. 2018, 78, 201\u2013209. 10.1016/j.bioorg.2018.03.022.", "ArticleIdList": ["10.1016/j.bioorg.2018.03.022", "29597114"]}, {"Citation": "Elrayess R.; Ghareb N.; Azab M. M.; Said M. M. Synthesis and antimicrobial activities of some novel benzimidazole and benzotriazole derivatives containing \u03b2-lactam moiety. Life Sci. J. 2013, 10, 1784\u20131793."}, {"Citation": "Eisa H. M.; Barghash A.-e. M.; Badr S. M.; Farahat A. A. Synthesis and antimicrobial activity of certain benzimidazole and fused benzimidazole derivatives. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 2010, 49, 1515\u20131525."}, {"Citation": "Kashtoh H.; Hussain S.; Khan A.; Saad S. M.; Khan J. A. J.; Khan K. M.; Perveen S.; Choudhary M. I. Oxadiazoles and thiadiazoles: Novel \u03b1-glucosidase inhibitors. Bioorg. Med. Chem. 2014, 22, 5454\u20135465. 10.1016/j.bmc.2014.07.032.", "ArticleIdList": ["10.1016/j.bmc.2014.07.032", "25151088"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "4", "Day": "3"}, {"Year": "2022", "Month": "7", "Day": "15"}, {"Year": "2022", "Month": "8", "Day": "22", "Hour": "3", "Minute": "55"}, {"Year": "2022", "Month": "8", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "23", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "8", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["35990459", "PMC9386811", "10.1021/acsomega.2c01969"]}}], "PubmedBookArticle": []}